Aridis Pharmaceuticals Dividend
Dividend criteriumcontroles 0/6
Aridis Pharmaceuticals does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-153,844.7%
Terugkoop Rendement
Totaal aandeelhoudersrendement | -153,844.7% |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Aridis Pharmaceuticals announces proposed public stock offering; shares down ~30%
Sep 26Aridis Pharmaceuticals GAAP EPS of -$0.45, revenue of $0.29M
Aug 16Can You Imagine How Aridis Pharmaceuticals' (NASDAQ:ARDS) Shareholders Feel About The 32% Share Price Increase?
Feb 17Aridis Pharmaceuticals EPS misses by $0.02
Nov 20Aridis Pharmaceuticals (ARDS) Investor Presentation - Slideshow
Oct 31Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if ARDS's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if ARDS's dividend payments have been increasing.
Dividendrendement versus markt
Aridis Pharmaceuticals Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (ARDS) | n/a |
Markt onderkant 25% (US) | 1.5% |
Markt Top 25% (US) | 4.5% |
Gemiddelde industrie (Biotechs) | 2.2% |
Analist prognose (ARDS) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate ARDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate ARDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate ARDS's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as ARDS has not reported any payouts.